Pfizer Tumbles Beside a Triple-Digit Plunge for the Dow

United Technologies also falls sharply on a downbeat day for stocks across the markets.

Mar 13, 2014 at 2:30PM
Daily Fool

The markets have taken a beating today, with the Dow Jones Industrial Average (DJINDICES:^DJI) leaving investors shaking their heads with a 193-point fall as of 2:30 p.m. EDT. All but two of its blue-chip member stocks are down for the day. Despite a positive economic report this morning, Dow laggard Pfizer (NYSE:PFE) has fallen near the bottom of the index in losing 2.1% -- behind only the Dow's worst stock on the day, United Technologies (NYSE:UTX), which has slipped 2.3%. Let's catch up on what you need to know.

Retail noses higher, but stocks plummet
The economy kicked things off on a positive note for such a downbeat day, when the Commerce Department showed that retail sales moved higher by 0.3% in February. The seasonally adjusted gain marked the first jump in retail sales in three months after January and December delivered sharp drops for the sector; adjusted department reports for those two months showed losses that were even worse than initially reported. The weather's likely the biggest culprit for those two months' lackluster performance, but the retail sector overall has found growth wanting over the past year. Don't expect sales gains to come in leaps and bounds in the coming months; a slow trickle of growth is more likely, even as the weather improves.

That's no consolation to Big Pharma's Pfizer, whose fall comes despite positive news of its own. Standout vaccine Prevnar 13 already has become one of the company's best-sellers, and Pfixzer announced that Prevnar vaccination in testing greatly reduced the likelihood of seniors contracting pneumonia or other pneumococcal diseases. Pneumonia rates were cut by a whopping 46%  in the 85,000-member trial

How big could the study be for Pfizer? Prevnar already rakes in about $4 billion in annual sales for the company, but analysts project that the strong showing could add up to $1.5 billion in annual sales for the vaccine down the road, with J.P. Morgan projecting a possible $300 million in adult sales from the vaccine by next year. That's little consolation for investors with the stock's drop today, but in the long run it's a great win for Pfizer as it beefs up its sales portfolio after the patent expiration of Lipitor.

United Technologies sits at the bottom of the index after the industrial conglomerate left investors disappointed today. The company announced a long-term revenue target that anticipatesannual growth of middle single-digit percentages through 2020. UTC also projected sales of roughly $64 billion in 2014, a slight gain after recording 9% sales growth in fiscal year 2013. However, the company's projection of $1.25 per-share first-quarter earnings today fell below analyst expectations of $1.38 per share, and investors have to hope that UTC is right about a brightening future for beleaguered helicopter-making subsidiary Sikorsky, which dragged down sales last quarter in seeing revenue fall 13% year over year. In today's budget-tightening world of the Department of Defense, however, don't grow too optimistic about that just yet.

This stock could crush the Dow's gains in 2014
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Dan Carroll has no position in any stocks mentioned. The Motley Fool owns shares of JPMorgan Chase. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.

 


Compare Brokers